No Proof Found That Genetic Testing Helps Prevent Blood Clots According to a new report by HHS' Agency for Healthcare Research and Quality, there is insufficient evidence to conclude that genetic testing for two gene mutations in adults with a history of blood clots helps to prevent a condition known as deep-vein thrombosis or to improve other clinical outcomes.
Source: www.medicalnewstoday.comWhy take cholesterol-lowering drugs when cholesterol is not high? DEAR DR. DONOHUE: My doctor wants me to take a statin drug even though my total cholesterol is normal and my LDL cholesterol isn’t very high. The only other abnormal test was the CRP test. He says that a statin for someone like me has been shown to prevent heart attacks. My father died of [...]
Source: feedproxy.google.comLytix Biopharma And KAEL-GemVax Announce Joint Clinical Trial To Combine LTX-315 And GV1001 Cancer Immunotherapy The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax announced the signing of a collaborative agreement to test lead compounds LTX-315 and GV1001 as a combination therapy for the treatment of cancer. According to Lytix Biopharma CEO Gunnar Saelid and KAEL-GemVax CEO Jay Sangjae Kim, "We are delighted to announce this joint venture to test a combination of two very interesting experimental drugs.
Source: www.medicalnewstoday.comAvir Green Hills: Excellent Preclinical Data On Novel Type Of Intranasal H5N1 Influenza Vaccine Studies performed in three animal models confirmed the safety and intensive immunogenicity of a new type of intranasal H5N1 influenza vaccine, according to the latest preclinical study data announced today by the Vienna based firm, Avir Green Hills Biotechnology. The study data was just published in PloS One, the Public Library of Science. "The intranasal immunization with our vaccine has proven itself capable of generating a strong immune response against H5N1 viruses.
Source: www.medicalnewstoday.com
# posted by Network @ 10:48 PM
